COMBINED BROMOCRIPTINE-LEVODOPA THERAPY EARLY IN PARKINSONS-DISEASE

被引：144
|
作者：
RINNE, UK
机构：
来源：
NEUROLOGY | 1985年 / 35卷 / 08期
关键词：
D O I：
10.1212/WNL.35.8.1196
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：1196 / 1198
页数：3
相关论文
共 50 条
  • [21] BROMOCRIPTINE AND PARKINSONS-DISEASE
    BORIE, F
    REVUE DE MEDECINE, 1978, 19 (28-2): : 1553 - 1561
  • [22] COMBINED LEVODOPA-ANTICHOLINERGIC THERAPY IN THE TREATMENT OF PARKINSONS-DISEASE - EFFECT ON LEVODOPA BIOAVAILABILITY
    CONTIN, M
    RIVA, R
    MARTINELLI, P
    PROCACCIANTI, G
    ALBANI, F
    BARUZZI, A
    CLINICAL NEUROPHARMACOLOGY, 1991, 14 (02) : 148 - 155
  • [23] PARKINSONS-DISEASE AND LEVODOPA
    不详
    WEST VIRGINIA MEDICAL JOURNAL, 1977, 73 (05) : 108 - 108
  • [24] COMBINED TREATMENT WITH DOPA AND BROMOCRIPTINE IN CHRONIC PARKINSONS-DISEASE
    SELBY, G
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 1988, 18 (03): : 485 - 485
  • [25] LOW-DOSE BROMOCRIPTINE ADDED TO LEVODOPA IN THE TREATMENT OF PARKINSONS-DISEASE
    MASSETANI, R
    PICCINI, P
    MURRI, L
    MURATORIO, A
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1989, 46 (02): : 210 - 215
  • [26] EVALUATION OF CHRONIC LEVODOPA THERAPY IN PARKINSONS-DISEASE
    BATTISTIN, L
    BRACCO, F
    SALADINI, M
    JOURNAL OF NEURAL TRANSMISSION, 1986, : 201 - 207
  • [27] A CASE FOR EARLY LEVODOPA TREATMENT OF PARKINSONS-DISEASE
    CARACENI, T
    CLINICAL NEUROPHARMACOLOGY, 1994, 17 : S38 - S42
  • [28] LEVODOPA THERAPY AND MOTOR FLUCTUATIONS IN PARKINSONS-DISEASE
    OBESO, JA
    LUQUIN, MR
    GRANDAS, F
    VAAMONDE, J
    LAGE, JMM
    ANNALS OF NEUROLOGY, 1988, 24 (05) : 696 - 697
  • [29] FACTORS PREDICTIVE OF THE NEED FOR LEVODOPA THERAPY IN EARLY, UNTREATED PARKINSONS-DISEASE
    MCDERMOTT, MP
    JANKOVIC, J
    CARTER, J
    FAHN, S
    GAUTHIER, S
    GOETZ, CG
    GOLBE, LI
    KOLLER, W
    LANG, AE
    OLANOW, CW
    SHOULSON, I
    STERN, MB
    TANNER, CM
    WEINER, WJ
    ARCHIVES OF NEUROLOGY, 1995, 52 (06) : 565 - 570
  • [30] EARLY SELEGILINE THERAPY REDUCES LEVODOPA DOSE REQUIREMENT IN PARKINSONS-DISEASE
    MYLLYLA, VV
    HEINONEN, EH
    VUORINEN, JA
    KILKKU, OI
    SOTANIEMI, KA
    ACTA NEUROLOGICA SCANDINAVICA, 1995, 91 (03): : 177 - 182
12345